When someone develops memory loss or cognitive concerns, doctors typically start with a blood panel to rule out treatable medical conditions that can mimic dementia. These tests screen for vitamin deficiencies (particularly B12 and folate), thyroid disease, infections, metabolic disorders, and medication side effects—conditions that can cause memory problems but are reversible once treated. For example, a 67-year-old woman who presented with significant forgetfulness and confusion was found to have severely low vitamin B12 levels; after supplementation, her cognitive symptoms resolved completely within weeks. The specific blood tests ordered depend on the patient’s age, symptoms, medical history, and initial clinical evaluation.
There is no single “memory loss test,” but rather a combination of routine labs that neurologists and primary care physicians use to narrow down the cause. These might include a complete metabolic panel, thyroid-stimulating hormone (TSH), vitamin B12 and folate levels, homocysteine, and screening for infections like syphilis or HIV. Some doctors also check inflammatory markers or genetic risk factors like apolipoprotein E (APOE) status when Alzheimer’s disease is suspected. The goal is practical: blood tests are inexpensive, non-invasive, and can identify correctable problems before proceeding to more expensive imaging studies like MRI or PET scans. They serve as a first filter in the diagnostic process.
Table of Contents
- Which Blood Tests Are Most Commonly Ordered for Memory Concerns?
- What Do Blood Tests Miss, and Why Imaging May Still Be Necessary?
- Why Are Infection Screening Tests Sometimes Included?
- How Do Doctors Decide Which Tests to Order?
- What Are the Limitations of Blood Tests for Detecting Cognitive Disease?
- Genetic Testing and Apolipoprotein E Status
- What Happens After Blood Tests Come Back?
- Frequently Asked Questions
Which Blood Tests Are Most Commonly Ordered for Memory Concerns?
A standard memory loss workup typically includes a complete metabolic panel (CMP), which measures electrolytes, glucose, kidney and liver function. Abnormalities here—such as high sodium, low glucose, or liver dysfunction—can all affect cognition. Thyroid function tests, specifically TSH and free T4, are nearly always included because hypothyroidism is common, easily missed, and treatable. An underactive thyroid slows metabolism throughout the body including the brain, producing memory loss that can be indistinguishable from early dementia.
Vitamin B12 and folate are checked because deficiencies are surprisingly common in older adults, especially those on certain medications like metformin for diabetes. The neurological damage from B12 deficiency can include memory problems, confusion, and even permanent nerve damage if caught too late. Homocysteine levels, often ordered alongside B12, rise when B vitamins are insufficient; elevated homocysteine itself is associated with cognitive decline and vascular disease. A patient with malabsorption from celiac disease or previous gastric surgery might have subtle B12 deficiency that shows up only through these blood tests, not obvious symptoms.
What Do Blood Tests Miss, and Why Imaging May Still Be Necessary?
While blood tests are a valuable first step, they cannot diagnose Alzheimer’s disease or other neurodegenerative conditions directly. They rule things out but don’t confirm that brain atrophy or amyloid plaques are present. A person can have completely normal blood work and still have active Alzheimer’s pathology. This is a critical limitation: normal labs do not mean the memory loss is benign.
If blood work comes back reassuring but cognitive decline continues, the next step is typically brain imaging—MRI or sometimes PET scanning—to visualize structural changes. Certain newer blood biomarkers like phosphorylated tau and amyloid-beta ratios can help predict Alzheimer’s risk, but these are not routinely ordered and are not yet standard clinical practice in all settings. Insurance often doesn’t cover them, and their clinical utility for individual patient management is still being defined. A neurologist might order these specialized tests if there’s strong clinical suspicion of Alzheimer’s and the patient is considering entering a research study or starting a disease-modifying therapy, but a primary care doctor doing an initial workup typically will not.
Why Are Infection Screening Tests Sometimes Included?
Depending on patient history, blood tests may include screening for syphilis (RPR or VDRL) and HIV antibodies. Both infections can cause neurological damage and memory loss, and syphilis-related cognitive decline has re-emerged in some populations. Someone with a remote sexual history, injection drug use history, or other risk factors should be screened. These tests are inexpensive and important because late neurosyphilis (neurocognitive syphilis) is treatable with antibiotics if caught, whereas untreated it causes progressive dementia.
Thyroid antibodies may also be checked if autoimmune thyroid disease is suspected. In rare cases, autoimmune encephalitis—an inflammation of the brain due to antibodies attacking brain tissue—presents as cognitive decline or memory loss. Blood tests can reveal antineuronal antibodies or other autoimmune markers. One case involved a middle-aged woman whose rapidly progressive memory loss was initially attributed to Alzheimer’s, but blood work revealed autoimmune markers; she received immunosuppressive therapy and partially recovered, whereas standard dementia progression would have been relentless.
How Do Doctors Decide Which Tests to Order?
The decision to order specific blood tests depends on clinical presentation and risk factors. A patient presenting with acute memory loss over weeks is worked up differently from someone with slow decline over years. Acute onset raises suspicion for infection, medication toxicity, or metabolic derangement—conditions that come and go rapidly. Gradual onset over years is more consistent with neurodegenerative disease, but doctors still order routine labs to exclude reversible causes. Age and medical history matter enormously.
An 85-year-old with diabetes and kidney disease might need different tests than a 60-year-old with no prior medical problems. Medications are also critical: someone taking multiple sedating drugs might have memory loss simply from over-medication, a concern that’s identified through detailed history and medication review rather than any single blood test. The doctor’s judgment determines the scope. A neurologist seeing a patient referred specifically for dementia evaluation will order a more extensive panel than a primary care visit for general memory complaints. There’s a tradeoff between thoroughness and practicality—ordering dozens of tests is expensive and time-consuming, while ordering too few risks missing a treatable condition.
What Are the Limitations of Blood Tests for Detecting Cognitive Disease?
Blood tests have a fundamental limitation: they measure substances in the bloodstream, not brain pathology directly. A normal complete metabolic panel does not exclude stroke, tumor, or degenerative disease affecting the brain. Blood tests are insensitive for detecting these structural problems. Someone could have a brain tumor the size of a walnut causing memory loss, and routine blood work would be entirely normal.
This is why normal blood tests must be followed by imaging if the clinical picture remains concerning. Another limitation is that many blood tests have wide normal ranges and variable interpretation. A B12 level of 300 pg/mL is technically “normal” by many labs’ reference ranges, but some experts argue that levels below 500 are associated with cognitive symptoms and should be supplemented. Different labs use different cutoffs, and the same result might be interpreted differently by different doctors. A patient getting a second opinion might find that one neurologist says the B12 is low enough to treat, while another says it’s fine—a frustrating inconsistency that reflects genuine disagreement in the field about how aggressively to treat borderline values.
Genetic Testing and Apolipoprotein E Status
Some doctors order apolipoprotein E (APOE) genotyping when Alzheimer’s disease is suspected. The APOE4 variant is associated with significantly increased Alzheimer’s risk, while APOE2 is somewhat protective. However, APOE status alone cannot diagnose Alzheimer’s or confirm that memory loss will develop. Many people with the APOE4 variant never develop dementia, and some without it do.
The test provides statistical risk information but not a definitive answer. Genetic counseling is recommended before and after APOE testing because the results can cause anxiety. A patient learning they carry APOE4 might assume they will inevitably develop Alzheimer’s, which is not accurate. The test is most useful when combined with other biomarkers and clinical data, not as a standalone answer to memory concerns.
What Happens After Blood Tests Come Back?
Once blood work is complete, the doctor reviews results in the context of the patient’s symptoms, exam findings, and cognitive testing (such as the Montreal Cognitive Assessment or Mini-Cog). If reversible causes are found—vitamin deficiency, thyroid disease, medication toxicity—those are treated first, and the memory loss often improves. If blood work is unremarkable but cognitive decline continues, neuroimaging is the next step to look for structural disease. Some blood results suggest the need for specialist referral.
A positive syphilis screen prompts treatment by infectious disease. Abnormal liver or kidney function might explain cognitive symptoms through metabolic derangement and directs focus to treating the underlying organ problem. When blood tests are normal and imaging is normal but the patient is still declining cognitively, the workup becomes more challenging and may include advanced biomarker testing, neuropsychological evaluation, or specialist neurology consultation. The blood tests are a beginning, not an ending—they narrow possibilities and guide the next diagnostic steps.
Frequently Asked Questions
Can a blood test diagnose Alzheimer’s disease?
Routine blood tests cannot diagnose Alzheimer’s. New biomarker tests (phosphorylated tau, amyloid-beta) show promise for predicting Alzheimer’s risk, but these are not yet standard practice and are often not covered by insurance. A diagnosis of Alzheimer’s still requires either brain imaging or, definitively, brain tissue examination after death.
What if my blood tests are normal but I still have memory loss?
Normal blood work is reassuring—it rules out many treatable conditions—but doesn’t exclude brain disease like Alzheimer’s, stroke, or tumor. Your doctor should order brain imaging (MRI or CT scan) to look for structural problems. Cognitive testing by a neuropsychologist may also be recommended.
How often should blood tests be repeated if the first workup was normal?
Routine labs are often repeated annually during annual physical exams. If memory loss is worsening rapidly despite normal initial workup, repeat testing sooner may be warranted to catch newly developed vitamin deficiencies or metabolic problems. Your doctor will advise based on your specific situation.
Is the APOE genetic test something I should request?
APOE testing is not recommended for everyone. It’s most useful if you’re participating in research, considering preventive treatment, or have a strong family history of Alzheimer’s. The test reveals statistical risk, not certainty, and results can cause unnecessary anxiety. Discuss with your doctor whether this test makes sense in your situation.
Why don’t doctors just do brain imaging instead of blood tests?
Blood tests are inexpensive, fast, and can identify several treatable conditions that would be missed by imaging alone. They’re also less expensive than MRI or PET scans, which cost hundreds to thousands of dollars. Blood tests serve as an efficient first filter; imaging follows if needed.
Can medication side effects show up on blood tests?
Some medications do—for example, antihistamines or antidepressants might slightly alter electrolytes or glucose. However, cognitive side effects from medications like sedatives or anticholinergics are usually identified through medication history and review, not blood work itself. Your doctor will ask detailed questions about all medications and supplements you’re taking.
